医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market

2024年03月29日 AM11:09
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

BODYDOCTOR, an innovative healthcare device developed by GENERALNET CORP is rapidly gaining traction around the world. This innovative solution enables people to do Kegel exercises easily by sitting on it, heralding a new era of K-HEALTH CARE.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240327264174/en/

The EMS Kegel Trainer BODYDOCTOR FEMFIT has been launched in Japan. (Photo: GENERALNET CORP)

The EMS Kegel Trainer BODYDOCTOR FEMFIT has been launched in Japan. (Photo: GENERALNET CORP)

Derived from combining ‘Feminine’ and ‘Care’, the term ‘Femcare’ encompasses products and services designed to care for women’s bodies and health.

Women face various health problems, including light incontinence, nocturia, and uterine prolapse attributed to premenstrual syndrome (PMS), menstrual irregularities, diminished vaginal elasticity during pregnancy and postpartum, menopausal symptoms, and hormonal imbalances.

Understanding how important it is to strengthen pelvic floor muscles to address these health issues, GENERALNET CORP, a company dedicated to women’s health and beauty, launched the EMS Kegel exerciser BODYDOCTOR in January 2019. Pelvic floor muscles are a general term for the muscles at the base of the pelvis; They are crucial for supporting bladder, uterus, and rectum, akin to a hammock, contributing significantly to overall well-being.

BODYDOCTOR garnered favorable reviews from many Korean celebrities and influencers after its launch. Rapidly emerging as a leading K healthcare solution, it generated sales of around KRW 200 billion in the last five years. It is well-received globally, with many potential buyers in countries like Japan, China, the Middle East, the US, Vietnam, and Thailand.

Besides the growing preference for Korean brands, the proven benefits of hip muscle development and hip-up effects have further contributed to the positive reception from buyers.

Kegel exercises offer numerous advantages, including the strengthening of pelvic floor muscles, mitigation of urinary incontinence and nocturia, enhancement of abdominal elasticity, and lifting of the hips. Nevertheless, it is challenging to accurately find the pelvic floor muscles and adhere to a daily Kegel exercise routine.

BODYDOCTOR is designed to address these challenges. It offers a user-friendly solution, letting people do Kegel exercises easily while sitting. With just 30 minutes of daily use, this device uses a unique EMS low-frequency stimulation and a customizable program with intensity levels ranging from 1 to 99 to accommodate individual physical attributes. It effectively induces contraction and relaxation of targeted muscles, leading to definitive exercise outcomes.

This device, which enables users to experience the benefits of exercise by simply sitting for 30 minutes while reading, watching TV, or resting, was developed to facilitate convenient and consistent Kegel exercises amidst busy daily schedules. Its efficacy in promoting Kegel exercise was proved through the results of a product effectiveness test conducted at Yongin University.

Following its successful debut in Japan at FEMTECH in Tokyo Big Sight in October 2023, BODYDOCTOR has gained enthusiastic reviews. It is now available in Japan under the product name BODYDOCTOR Femfit.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240327264174/en/

CONTACT

GENERALNET CORP

Jang Hyeonjeong

+82 70-4827-5402

hjjang@gngroup.co.kr

同じカテゴリーの記事 

  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
  • Masimo创始人兼首席执行官Joe Kiani将在智利举行的全球患者安全峰会上谈论人工智能
  • マシモ創業者兼最高経営責任者(CEO)のジョー・キアニがチリで開催される世界患者安全サミットでAIについて講演
  • Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)